Medical News

RSS
Results from Celgene’s ABRAXANE plus gemcitabine clinical study on resectable pancreatic cancer

Results from Celgene’s ABRAXANE plus gemcitabine clinical study on resectable pancreatic cancer

HCMS, ACOEM announce important expansion to Blueprint for Health

HCMS, ACOEM announce important expansion to Blueprint for Health

Ipsen, Active Biotech present OS data from tasquinimod Phase II study on CRPC at ASCO 2012

Ipsen, Active Biotech present OS data from tasquinimod Phase II study on CRPC at ASCO 2012

A.M. Best upgrades FSR and ICR for ODSHP

A.M. Best upgrades FSR and ICR for ODSHP

Alnylam announces results from ALN-VSP Phase I study on liver cancers

Alnylam announces results from ALN-VSP Phase I study on liver cancers

BIOREM closes private placement

BIOREM closes private placement

High doses of ginseng more effectively reduce cancer-related fatigue in patients

High doses of ginseng more effectively reduce cancer-related fatigue in patients

ASS234 molecule inhibits aggregation of the Alzheimer's protein

ASS234 molecule inhibits aggregation of the Alzheimer's protein

Senesco reports on the progress of SNS01-T Phase 1b/2a study for multiple myeloma

Senesco reports on the progress of SNS01-T Phase 1b/2a study for multiple myeloma

Researchers uncover brain signaling pathway responsible for renal excretory function

Researchers uncover brain signaling pathway responsible for renal excretory function

Exelixis reports data from cabozantinib phase 3 trial on MTC

Exelixis reports data from cabozantinib phase 3 trial on MTC

Researchers uncover cellular basis for age-related breast cancer vulnerability

Researchers uncover cellular basis for age-related breast cancer vulnerability

Promising data from Array BioPharma’s MEK162 Phase 2 trial on BRAF and NRAS mutant melanoma

Promising data from Array BioPharma’s MEK162 Phase 2 trial on BRAF and NRAS mutant melanoma

Religious practices more successful at promoting certainty about paternity

Religious practices more successful at promoting certainty about paternity

OncoGenex announces data from OGX-427 Phase 2 study on mCRPC

OncoGenex announces data from OGX-427 Phase 2 study on mCRPC

Force 3 acquires secureRAD

Force 3 acquires secureRAD

Chatham, Baxter partner to develop and commercialize hemophilia B gene therapy treatment

Chatham, Baxter partner to develop and commercialize hemophilia B gene therapy treatment

Positive results from BioSpecifics’ XIAFLEX Phase III clinical program on Peyronie's disease

Positive results from BioSpecifics’ XIAFLEX Phase III clinical program on Peyronie's disease

IRadimed receives Novation contract for MRidium MRI Infusion Pump Systems

IRadimed receives Novation contract for MRidium MRI Infusion Pump Systems

Preliminary results from Incyte’s INCB024360 Phase I trial on solid tumors

Preliminary results from Incyte’s INCB024360 Phase I trial on solid tumors

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.